Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank36
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P36
Within normal range
Average
-71023.84%
Historical baseline
PeriodValueYoY Change
20240.00%-
20230.00%-
20220.00%-
20210.00%-
20200.00%-
20190.00%-
20180.00%-
20170.00%-
20160.00%+100.0%
2015-710238.40%-